Weekend, January 14-15 (CogLabs Newswire)
The drug Namenda slows Alzheimer's diseasse for at least a year,
doctors report in the Archives of Neurology.
Namenda, which was approved by the FDA in 2003, had already fared well in a study that lasted about seven months. The new results come from an extension of that study.
The Alzheimer's Association estimates that 4.5 million people
in the U.S. have Alzheimer's disease. Alzheimer's is the most common form of
dementia in older adults. However, it's not a normal part of aging.
Alzheimer's disease affects parts of the brain involved in
memory, intelligence, judgment, language, and behavior. Its exact cause isn't
known, and no cure exists.The study was funded by Merz Pharmaceuticals GmBH, which markets Namenda in Germany.